Gilead Sciences
GILD
#81
Rank
S$270.26 B
Marketcap
S$217.90
Share price
-0.75%
Change (1 day)
34.77%
Change (1 year)

P/S ratio for Gilead Sciences (GILD)

P/S ratio as of November 2026 (TTM): 6.75

According to Gilead Sciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 17.8. At the end of 2026 the company had a P/S ratio of 5.79.

P/S ratio history for Gilead Sciences from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20265.7913.01%
20255.1225.64%
20244.089.57%
20233.72-5.68%
20223.9518.36%
20213.3312.73%
20202.96-19.28%
20193.661.12%
20183.621.1%
20173.5815.47%
20163.10-29.58%
20154.41-22.34%
20145.68-44.82%
201310.378.9%
20125.7556.83%
20113.670.28%
20103.66-34.16%
20095.55-36.37%
20088.73-13.63%
200710.12.11%
20069.89-16.96%
200511.90.5%
200411.9-17.21%
200314.3-0.5%
200214.4-46.96%
200127.1

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.66-1.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
2.52-62.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
7.68 13.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
14.3 112.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
6.18-8.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
3.62-46.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
7.14 5.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
10.6 56.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
5.05-25.16%๐Ÿ‡บ๐Ÿ‡ธ USA